S

Syncom Formulations (India) Ltd
NSE:SYNCOMF

Watchlist Manager
Syncom Formulations (India) Ltd
NSE:SYNCOMF
Watchlist
Price: 14.46 INR 2.7%
Market Cap: 13.6B INR

Syncom Formulations (India) Ltd
Common Stock

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Syncom Formulations (India) Ltd
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
S
Syncom Formulations (India) Ltd
NSE:SYNCOMF
Common Stock
₹844.1m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Common Stock
₹835m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Common Stock
₹1.6B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Common Stock
₹2.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Lupin Ltd
NSE:LUPIN
Common Stock
₹913.2m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Common Stock
₹1.7B
CAGR 3-Years
0%
CAGR 5-Years
15%
CAGR 10-Years
7%
No Stocks Found

Syncom Formulations (India) Ltd
Glance View

Market Cap
13.6B INR
Industry
Pharmaceuticals

Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Indore, Madhya Pradesh. The firm manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquid orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments and inhalers. Its segments include Pharmaceuticals Drugs & Formulations, Trading of Commodities and Renting of property. Its product categories include tablets, capsules, ointments, injections, liquid-oral and packaging variants. The company offers various products, including generics, alpha adrenoceptor agonist, analgesic, antipyretic, anti-inflammatory, anti-ulcer agents, antibiotic, antidepressant, antiviral, cephelo sporins, cortico steroid, estrogen, cough suppressant and sedative anticonvulsant, among others. The firm operates in more than 15 countries across the world.

SYNCOMF Intrinsic Value
HIDDEN
Show

See Also

What is Syncom Formulations (India) Ltd's Common Stock?
Common Stock
844.1m INR

Based on the financial report for Mar 31, 2025, Syncom Formulations (India) Ltd's Common Stock amounts to 844.1m INR.

What is Syncom Formulations (India) Ltd's Common Stock growth rate?
Common Stock CAGR 3Y
-1%

Over the last year, the Common Stock growth was -10%. The average annual Common Stock growth rates for Syncom Formulations (India) Ltd have been -1% over the past three years .

Back to Top